Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Association between BDNF Val66Met polymorphism and Alzheimer disease, dementia with Lewy bodies, and Pick disease.

Fehér A, Juhász A, Rimanóczy A, Kálmán J, Janka Z.

Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):224-8. doi: 10.1097/WAD.0b013e318199dd7d.

PMID:
19812463
2.

Association between a genetic variant of the alpha-7 nicotinic acetylcholine receptor subunit and four types of dementia.

Fehér A, Juhász A, Rimanóczy A, Csibri E, Kálmán J, Janka Z.

Dement Geriatr Cogn Disord. 2009;28(1):56-62. doi: 10.1159/000230036. Epub 2009 Jul 29.

PMID:
19641318
3.

Variations in the BDNF gene in autopsy-confirmed Alzheimer's disease and dementia with Lewy bodies in Japan.

Akatsu H, Yamagata HD, Kawamata J, Kamino K, Takeda M, Yamamoto T, Miki T, Tooyama I, Shimohama S, Kosaka K.

Dement Geriatr Cogn Disord. 2006;22(3):216-22. Epub 2006 Aug 7.

4.

A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele.

Riemenschneider M, Schwarz S, Wagenpfeil S, Diehl J, Müller U, Förstl H, Kurz A.

Mol Psychiatry. 2002;7(7):782-5.

5.

Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.

Borroni B, Archetti S, Costanzi C, Grassi M, Ferrari M, Radeghieri A, Caimi L, Caltagirone C, Di Luca M, Padovani A; ITINAD Working Group.

Neurobiol Aging. 2009 Sep;30(9):1406-12. doi: 10.1016/j.neurobiolaging.2007.11.023. Epub 2008 Jan 7.

PMID:
18179845
6.

Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.

Hashimoto R, Hirata Y, Asada T, Yamashita F, Nemoto K, Mori T, Moriguchi Y, Kunugi H, Arima K, Ohnishi T.

Genes Brain Behav. 2009 Feb;8(1):43-52. doi: 10.1111/j.1601-183X.2008.00440.x. Epub 2008 Sep 11.

7.
8.

The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.

Bosco P, Caraci F, Copani A, Spada RS, Sortino MA, Salluzzo R, Salemi M, Nicoletti F, Ferri R.

Neurosci Lett. 2007 Jun 4;419(3):195-8. Epub 2007 Apr 8.

PMID:
17498878
9.

Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease.

Nacmias B, Piccini C, Bagnoli S, Tedde A, Cellini E, Bracco L, Sorbi S.

Neurosci Lett. 2004 Sep 9;367(3):379-83.

PMID:
15337270
10.

Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.

Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T.

Neurosci Lett. 2005 Feb 25;375(1):1-6. Epub 2004 Nov 26.

PMID:
15664112
11.

The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers.

Martínez MF, Martín XE, Alcelay LG, Flores JC, Valiente JM, Juanbeltz BI, Beldarraín MA, López JM, Gonzalez-Fernández MC, Salazar AM, Gandarias RB, Borda SI, Marqués NO, Amillano MB, Zabaleta MC, de Pancorbo MM.

BMC Neurosci. 2009 Sep 30;10:125. doi: 10.1186/1471-2202-10-125.

12.

Association of apolipoproteins e4 and c1 with onset age and memory: a study of sporadic Alzheimer disease in Taiwan.

Chuang WL, Hsieh YC, Wang CY, Kuo HC, Huang CC.

J Geriatr Psychiatry Neurol. 2010 Mar;23(1):42-8. doi: 10.1177/0891988709351804.

PMID:
20145290
13.

[Apolipoprotein E4 in dementia with Lewy bodies].

Carrillo García F, Gil Néciga E, Alberca R, García-Solís D, Millán J, Rodríguez Uranga JJ, Franco E, Mir P, Suárez A, García R, Serrano-Pozo A, Pérez-Díaz H, Polo J.

Neurologia. 2008 Apr;23(3):152-6. Spanish.

PMID:
18370334
14.

Cholesteryl ester transfer protein polymorphism D442G associated with a potential decreased risk for Alzheimer's disease as a modifier for APOE epsilon4 in Chinese.

Chen DW, Yang JF, Tang Z, Dong XM, Feng XL, Yu S, Chan P.

Brain Res. 2008 Jan 2;1187:52-7. Epub 2007 Nov 26.

PMID:
18036514
15.

Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.

Lee J, Fukumoto H, Orne J, Klucken J, Raju S, Vanderburg CR, Irizarry MC, Hyman BT, Ingelsson M.

Exp Neurol. 2005 Jul;194(1):91-6.

PMID:
15899246
16.

CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.

Smach MA, Charfeddine B, Lammouchi T, Harrabi I, Ben Othman L, Dridi H, Bennamou S, Limem K.

Neurosci Lett. 2008 Aug 1;440(2):145-9. doi: 10.1016/j.neulet.2008.05.076. Epub 2008 May 24.

PMID:
18555606
17.

Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.

Traykov L, Bayle AC, Latour F, Lenoir H, Seux ML, Hanon O, Péquignot R, Bert P, Moulin F, Cantegreil I, Wenisch E, Batouche F, Mehrabian S, Rotrou Jd, Rigaud AS.

J Neurol Sci. 2007 Jun 15;257(1-2):280-3. Epub 2007 Mar 6.

PMID:
17337010
18.

Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.

Orsitto G, Seripa D, Panza F, Franceschi M, Cascavilla L, Placentino G, Matera MG, Paris F, Capurso C, Solfrizzi V, Dallapiccola B, Pilotto A.

Dement Geriatr Cogn Disord. 2007;23(5):327-33. Epub 2007 Mar 19.

PMID:
17374951
19.

Lack of association between the BDNF gene Val66Met polymorphism and Alzheimer disease in a Chinese Han population.

He XM, Zhang ZX, Zhang JW, Zhou YT, Tang MN, Wu CB, Hong Z.

Neuropsychobiology. 2007;55(3-4):151-5. Epub 2007 Jul 26.

PMID:
17657167
20.

Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.

Martinez M, Campion D, Brice A, Hannequin D, Dubois B, Didierjean O, Michon A, Thomas-Anterion C, Puel M, Frebourg T, Agid Y, Clerget-Darpoux F.

Arch Neurol. 1998 Jun;55(6):810-6.

PMID:
9626772

Supplemental Content

Support Center